Pitt bioengineers create ultrasmall, light-activated electrode for neural stimulation

IMAGE: A laser shining onto an untethered, ultrasmall carbon fiber electrode to stimulate neurons via the photoelectric effect. view more  Credit: J. Mater. Chem. B, 2015,3, 4965-4978 – Reproduced by permission of The Royal Society of Chemistry. PITTSBURGH (February 15, 2019) … Neural stimulation is a developing technology that has beneficial therapeutic effects in neurological disorders,…

Brain-computer interface, promise of restoring communication discussed at AAAS presentation

Brain-computer interfaces promise to restore communication for individuals with severe speech and physical impairments. Current brain computer interfaces share many features of high-tech, conventional augmentative and alternative communication systems, but via direct brain link. Choosing the “right” brain-computer interface that maximizes reliability of the neural control signal and minimizes fatigue and frustration is critical. Jonathan…

Spare 10 minutes to make science leap forward

IMAGE: Mark Basham, project coordinator for the citizen science project demonstrates how to spot viruses. This will help train Artificial Intelligence systems! view more  Credit: Diamond Light Source, 2019 Today sees the launch of an innovative Citizen Science Project by Diamond Light Source, the UK’s national synchrotron science facility.The project uses a crowdsourcing model to call…

Artificial intelligence can predict survival of ovarian cancer patients

The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis. The trial, published in Nature Communications took place…

Why some brain tumors respond to immunotherapy

NEW YORK, NY (February 15, 2019)– Columbia researchers have learned why some glioblastomas–the most common type of brain cancer–respond to immunotherapy. The findings could help identify patients who are most likely to benefit from treatment with immunotherapy drugs and lead to the development of more broadly effective treatments. The study, led by Raul Rabadan, PhD,…

Patented drug therapy for lung condition has been exclusively optioned to Theratome Bio

IMAGE: This is Michael Coleman, president and CEO of Theratome Bio. view more  Credit: Theratome Bio INDIANAPOLIS — A patented Indiana University School of Medicine discovery that uses proteins, lipids and nucleic acids secreted by adult stem cells to treat Acute Respiratory Distress Syndrome, or ARDS, has been optioned to Theratome Bio, an Indianapolis-based life sciences…